We are live on
!
Find out more
BRC
Blue Ridge Capital Portfolio holdings
AUM
$215M
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.29B
AUM Growth
–
Cap. Flow
+$8.21B
Cap. Flow
% of AUM
99.15%
Top 10 Holdings %
Top 10 Hldgs %
36.87%
Holding
50
New
50
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$340M |
| 2 |
Owens Corning
OC
|
+$334M |
| 3 |
Citigroup
C
|
+$331M |
| 4 |
Liberty Global Class A
LBTYA
|
+$321M |
| 5 |
American International
AIG
|
+$318M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.9% |
| 2 | Communication Services | 20.75% |
| 3 | Healthcare | 16.89% |
| 4 | Financials | 12.02% |
| 5 | Industrials | 6.41% |
Similar funds
BG
JCM
CCM
EA
PVWM
PWAP
BWI
MCFIG
Blue Ridge Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Blue Ridge Capital, which disclosed 50 positions worth $8.29B. Its ten largest holdings account for 37% of the portfolio.
Its largest position is Thermo Fisher Scientific: 4,085,000 shares worth $346M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, followed by Communication Services and Healthcare.
- Blue Ridge Capital's largest Q2 2013 buy was Thermo Fisher Scientific: 4,085,000 shares worth $346M.
- Blue Ridge Capital's ten largest holdings make up 37% of its $8.29B portfolio in Q2 2013.
- Blue Ridge Capital disclosed 50 positions in Q2 2013, its first 13F filing on record.
Based on Blue Ridge Capital's 13F filing for Q2 2013, filed 14 Aug 2013.